secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2026-05-22T13:30:32+00:00
Accession:  0001477932-26-003403
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health Q1 revenue +31% to $17.93M; net loss widens to $2.81M
-------------------------------------------------------------------

- Q1 revenue $17.93M, up 31% YoY from $13.71M; adjusted revenue $18.40M (+34.2%).
- Net loss of ($2.81M) vs ($0.82M) in Q1 2025, driven by $1.15M in non-cash items.
- Total liabilities reduced $4.5M (-9.6%) to $42.54M; stockholders' equity up 7.6% to $19.83M.
- Adjusted EBITDA near breakeven at ($229,596); company expects positive EBITDA as revenues scale.
- Strategic investments in U.S. expansion via 18 Series platform; Q2 momentum continues.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793226003403/0001477932-26-003403-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793226003403/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-003403

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer